Shan-Ming Kuang

USPTO Granted Patents = 6 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 61(Granted Patents)

Company Filing History:

3 out of 4,945

Hoffmann-la Roche Inc.

patents

3 out of 3,684

Bristol-myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2009-2014

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8865735 - Solid forms of a pharmaceutically active substance (2014-10-21),

2. 8329912 - Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine (2012-12-11),

3. 8063076 - Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine (2011-11-22),

4. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2011-06-28),

5. 7829711 - Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dione (2010-11-09),

6. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2009-10-13),

Title: An Insight into the Innovations of Inventor Shan-Ming Kuang

Introduction

Shan-Ming Kuang, an accomplished inventor based in Florence, SC, has made significant contributions to the field of pharmaceuticals with a total of six patents to his name. His innovative work primarily focuses on developing solid forms of pharmaceutically active substances, showcasing his expertise and dedication to advancing healthcare solutions.

Latest Patents

Among his latest patents are the development of solid forms of a compound identified by a specific chemical formula, which presents new pharmaceutical applications. Additionally, he has innovatively worked on the solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine. This particular invention includes mono-sulfate and hemi-sulfate salts of the compound, along with their crystalline and amorphous forms, emphasizing their potential use in various pharmaceutical formulations.

Career Highlights

Shan-Ming Kuang has had an impactful career, contributing his knowledge and skills to prominent companies such as Bristol-Myers Squibb Company and Hoffmann-La Roche Inc. His work within these organizations highlights a strong background in pharmaceutical research and development, aiming to create effective medications for various health concerns.

Collaborations

Throughout his professional journey, Kuang has collaborated with accomplished professionals in the field, including Qi Gao and Thomas Cleary. These partnerships reflect his commitment to teamwork and the sharing of ideas to foster innovation in pharmaceuticals.

Conclusion

In summary, Shan-Ming Kuang exemplifies the spirit of innovation within the pharmaceutical industry. With his extensive patent portfolio and collaborative efforts, he continues to contribute significantly to the development of new medicinal solutions, ultimately aiming to improve patient outcomes and enhance healthcare globally.

This text is generated by artificial intelligence and may not be accurate.